Hepatobiliary Surgery and Nutrition

Papers
(The H4-Index of Hepatobiliary Surgery and Nutrition is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)73
Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional O54
Durvalumab plus tremelimumab in unresectable hepatocellular carcinoma54
Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel?43
A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights38
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease35
Hepatocellular carcinoma in non-alcoholic fatty liver disease—a review of an emerging challenge facing clinicians35
Development of a machine learning model to predict early recurrence for hepatocellular carcinoma after curative resection32
Optimization of the future remnant liver: review of the current strategies in Europe30
Biliary complications after liver transplantation: current perspectives and future strategies29
Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy28
Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients28
A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis27
Diagnosis-related Groups (DRG) pricing and payment policy in China: where are we?25
Gd-EOB-DTPA-enhanced MRI radiomic features for predicting histological grade of hepatocellular carcinoma24
Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients23
An overview of the Chinese healthcare system23
Cholangiocarcinoma: a review of the literature and future directions in therapy22
When a new definition overhauls perceptions of MAFLD related cirrhosis care22
0.050782918930054